newsfilter
← Latest News
GlobeNewswire·

Imago BioSciences Appoints Michael Arenberg to Chief Operating and Business Officer

SOUTH SAN FRANCISCO, Calif., March 23, 2022 (GLOBE NEWSWIRE) -- Imago BioSciences, Inc. ("Imago") (NASDAQ:IMGO), a clinical stage biopharmaceutical company discovering new medicines for the treatment of myeloproliferative neoplasms (MPNs), today annou